Andere Sprachen Compugen Ltd.

Aktien

Realtime-Estimate Cboe BZX Andere Börsenplätze 15:38:13 24.04.2024			% 5 Tage	% 1. Jan.
1.95 ^USD	-1.52%		-2.46%	0.00%

08.03.	COMPUGEN LTD. : Truist Securities behält seine Kaufempfehlung bei	ZM
05.03.	Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024

Compugen to Participate in Two Upcoming Investor Conferences	03.04.
Compugen : Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy	11.03.
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy	11.03.
Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024	07.03.
Compugen : To Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024	06.03.
Compugen: Q4 Earnings Snapshot	05.03.
Earnings Flash (CGEN) COMPUGEN Reports Q4 Revenue $33.5M	05.03.
Earnings Flash (CGEN) COMPUGEN Posts Q4 EPS $0.11	05.03.
Compugen : Form 6-K- Fourth quarter and full year 2023 results	05.03.
Earnings Flash (CW9) COMPUGEN Posts Q4 EPS $0.11	05.03.
Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	05.03.
Compugen Reports Fourth Quarter and Full Year 2023 Results	05.03.
Compugen to Present at the Leerink Partners Global Biopharma Conference 2024	26.02.
Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024	20.02.
Compugen names new chief medical officer	16.02.
Compugen Ltd. Announces Executive Changes	15.02.
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer	15.02.
Sector Update: Health Care Stocks Stronger Late Afternoon	19.12.
Sector Update: Health Care	19.12.
Looming Inflation Data Stifle US Equity Futures Pre-Bell	19.12.

Keine Ergebnisse zu dieser Suche